Menopause modulates homocysteine levels in diabetic and non-diabetic women (Q46509008)

22 December 2017

title

Menopause modulates homocysteine levels in diabetic and non-diabetic women (English)

1 reference

22 December 2017

author

Riccardo Ientile

6

1 reference

22 December 2017

author name string

G T Russo

1

1 reference

22 December 2017

A Di Benedetto

2

1 reference

22 December 2017

E Alessi

3

1 reference

22 December 2017

A Giandalia

4

1 reference

22 December 2017

A Gaudio

5

1 reference

22 December 2017

K V Horvath

7

1 reference

22 December 2017

B Asztalos

8

1 reference

22 December 2017

G Raimondo

9

1 reference

22 December 2017

D Cucinotta

10

1 reference

22 December 2017

publication date

1 June 2008

1 reference

22 December 2017

Journal of Endocrinological Investigation

published in

1 reference

22 December 2017

volume

31

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

546-551

1 reference

22 December 2017

Ischemic heart disease in women and the role of hormone therapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Diabetes mellitus and cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Plasma homocysteine and menopausal status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Increased plasma homocysteine after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Homocysteine and risk of cardiovascular disease among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Homocysteine and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Correlates of total homocysteine plasma concentration in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

Age Dependence of the Influence of Methylenetetrahydrofolate Reductase Genotype on Plasma Homocysteine Level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346406

The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.

21 January 2018

1 reference

12 December 2020

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.

1 reference

12 December 2020

Risk factors that attenuate the female coronary disease advantage

1 reference

12 December 2020

The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine

1 reference

12 December 2020

Myocardial Infarction in Young Women in Relation to Plasma Total Homocysteine, Folate, and a Common Variant in the Methylenetetrahydrofolate Reductase Gene

1 reference

12 December 2020

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Factors influencing plasma homocysteine levels in type 2 diabetes

1 reference

12 December 2020

Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Homocysteine and cardiovascular risk in patients with diabetes mellitus

1 reference

12 December 2020

Age and Gender Affect the Relation between Methylenetetrahydrofolate Reductase C677T Genotype and Fasting Plasma Homocysteine Concentrations in the Framingham Offspring Study Cohort

1 reference

12 December 2020

Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346406

1 reference

22 December 2017

release_job5fj3xojayxomswbfarcqtyu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/job5fj3xojayxomswbfarcqtyu

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017